TY - JOUR
T1 - Deep Learning–Based Automated Imaging Classification of ADPKD
AU - HALT Polycystic Kidney Disease Study Group
AU - Kim, Youngwoo
AU - Bu, Seonah
AU - Tao, Cheng
AU - Bae, Kyongtae T.
AU - Steinman, Theodore
AU - Wei, Jesse
AU - Czarnecki, Peter
AU - Pedrosa, Ivan
AU - Braun, William
AU - Nurko, Saul
AU - Remer, Erick
AU - Chapman, Arlene
AU - Martin, Diego
AU - Rahbari-Oskoui, Frederic
AU - Mittal, Pardeep
AU - Torres, Vicente
AU - Hogan, Marie C.
AU - El-Zoghby, Ziad
AU - Harris, Peter
AU - Glockner, James
AU - King, Bernard
AU - Perrone, Ronald
AU - Halin, Neil
AU - Miskulin, Dana
AU - Schrier, Robert
AU - Brosnahan, Godela
AU - Gitomer, Berenice
AU - Kelleher, Cass
AU - Masoumi, Amirali
AU - Patel, Nayana
AU - Winklhofer, Franz
AU - Grantham, Jared
AU - Yu, Alan
AU - Wang, Connie
AU - Wetzel, Louis
AU - Moore, Charity G.
AU - Bost, James E.
AU - Bae, Kyongtae
AU - Abebe, Kaleab Z.
AU - Miller, J. Philip
AU - Thompson, Paul A.
AU - Briggs, Josephine
AU - Flessner, Michael
AU - Meyers, Catherine M.
AU - Star, Robert
AU - Shayman, James
AU - Henrich, William
AU - Greene, Tom
AU - Leonard, Mary
AU - McCullough, Peter
N1 - Publisher Copyright:
© 2024 International Society of Nephrology
PY - 2024/6
Y1 - 2024/6
N2 - Introduction: The Mayo imaging classification model (MICM) requires a prestep qualitative assessment to determine whether a patient is in class 1 (typical) or class 2 (atypical), where patients assigned to class 2 are excluded from the MICM application. Methods: We developed a deep learning–based method to automatically classify class 1 and 2 from magnetic resonance (MR) images and provide classification confidence utilizing abdominal T2-weighted MR images from 486 subjects, where transfer learning was applied. In addition, the explainable artificial intelligence (XAI) method was illustrated to enhance the explainability of the automated classification results. For performance evaluations, confusion matrices were generated, and receiver operating characteristic curves were drawn to measure the area under the curve. Results: The proposed method showed excellent performance for the classification of class 1 (97.7%) and 2 (100%), where the combined test accuracy was 98.01%. The precision and recall for predicting class 1 were 1.00 and 0.98, respectively, with F1-score of 0.99; whereas those for predicting class 2 were 0.87 and 1.00, respectively, with F1-score of 0.93. The weighted averages of precision and recall were 0.98 and 0.98, respectively, showing the classification confidence scores whereas the XAI method well-highlighted contributing regions for the classification. Conclusion: The proposed automated method can classify class 1 and 2 cases as accurately as the level of a human expert. This method may be a useful tool to facilitate clinical trials investigating different types of kidney morphology and for clinical management of patients with autosomal dominant polycystic kidney disease (ADPKD).
AB - Introduction: The Mayo imaging classification model (MICM) requires a prestep qualitative assessment to determine whether a patient is in class 1 (typical) or class 2 (atypical), where patients assigned to class 2 are excluded from the MICM application. Methods: We developed a deep learning–based method to automatically classify class 1 and 2 from magnetic resonance (MR) images and provide classification confidence utilizing abdominal T2-weighted MR images from 486 subjects, where transfer learning was applied. In addition, the explainable artificial intelligence (XAI) method was illustrated to enhance the explainability of the automated classification results. For performance evaluations, confusion matrices were generated, and receiver operating characteristic curves were drawn to measure the area under the curve. Results: The proposed method showed excellent performance for the classification of class 1 (97.7%) and 2 (100%), where the combined test accuracy was 98.01%. The precision and recall for predicting class 1 were 1.00 and 0.98, respectively, with F1-score of 0.99; whereas those for predicting class 2 were 0.87 and 1.00, respectively, with F1-score of 0.93. The weighted averages of precision and recall were 0.98 and 0.98, respectively, showing the classification confidence scores whereas the XAI method well-highlighted contributing regions for the classification. Conclusion: The proposed automated method can classify class 1 and 2 cases as accurately as the level of a human expert. This method may be a useful tool to facilitate clinical trials investigating different types of kidney morphology and for clinical management of patients with autosomal dominant polycystic kidney disease (ADPKD).
KW - atypical cyst
KW - deep learning
KW - explainable artificial intelligence
KW - polycystic kidney disease
KW - risk factors
KW - total kidney volume
UR - http://www.scopus.com/inward/record.url?scp=85191490565&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85191490565&partnerID=8YFLogxK
U2 - 10.1016/j.ekir.2024.04.002
DO - 10.1016/j.ekir.2024.04.002
M3 - Article
C2 - 38899202
AN - SCOPUS:85191490565
SN - 2468-0249
VL - 9
SP - 1802
EP - 1809
JO - Kidney International Reports
JF - Kidney International Reports
IS - 6
ER -